Evaluating a Two Stage Intrapartum Fetal Assessment in India

November 19, 2020 updated by: Andrew D Weeks, University of Liverpool

Evaluating the Impact of Introducing a Two Stage Intrapartum Fetal Monitoring Assessment Using Intermittent Auscultation and Cardiotocography in a Government Hospital, Nagpur, India

An intrapartum fetal monitoring training programme (on intermittent auscultation and cardiotocography) will be delivered at Government Medical College (GMC) to all relevant staff. This quality improvement project and training evaluation aims to assess and evaluate the impact of this training. This will allow the investigators to understand if it is feasible and acceptable to staff, increases knowledge and improves patient outcomes.

Study Overview

Detailed Description

As part of Misoprostol or Oxytocin for Labour Induction (MOLI) randomised controlled trial (RCT) (CTRI no. NCT03749902), Government Medical College (GMC) plans to increase the number of cardiotocography (CTG) machines available on labour ward and provide a United Kingdom (UK) based obstetrician to deliver training on cardiotocography (CTG) interpretation in order to improve fetal monitoring for this high risk population.

An intrapartum fetal monitoring training programme (on intermittent auscultation and cardiotocography) will be delivered at Government Medical College (GMC) to all relevant staff. This quality improvement project and training evaluation aims to assess and evaluate the impact of this training. This will allow the investigators to understand if it is feasible and acceptable to staff, increases knowledge and improves patient outcomes. It will be done through staff questionnaires, pre-and-post test scores and by examining the effects on maternal and perinatal outcomes using Kirkpatrick's training evaluation.

The whole project aims:

  • To understand current practice and maternal and perinatal outcomes in Government Medical College (GMC)
  • To improve intrapartum fetal monitoring with intermittent auscultation and cardiotocography (CTG)
  • To improve perinatal morbidity and mortality rates
  • To reduce caesarean section rates for presumed fetal compromise

Study Type

Observational

Enrollment (Actual)

6682

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maharastra
      • Nagpur, Maharastra, United Kingdom, 440003
        • Government Medical College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

All women that deliver within the obstetrics department in Government Medical College (GMC) during the study period (8 months)

Description

Inclusion Criteria:

  • All women that deliver within the obstetrics department in Government Medical College (GMC) during the study period (8 months)

Exclusion criteria:

  • Deliveries in A&E/medical wards
  • Home deliveries
  • Patients delivered in other hospitals/ambulance deliveries
  • Macerated still birth
  • Fresh still birth with no fetal heart on admission to hospital

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Delivered women
Maternal and perinatal outcomes will be collected prospectively on all patients that deliver in Government Medical College (GMC) Hospital before, during and after the training over the study period (8 months) in order to evaluate the impact of the training.
Intrapartum fetal monitoring training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caesarean section performed for presumed fetal compromise as a prortion of all caesarean sections
Time Frame: 8 months
Percentage change of rate per month
8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intrapartum fetal monitoring - Improved documentation
Time Frame: 8 months

Average number of times fetal heart rate (FHR) documented per mother

• Number of times fetal heart rate (FHR) documented in labour

8 months
Intrapartum fetal monitoring - Improved documentation of fetal heart rate
Time Frame: 8 months

Average time between last FHR documented and delivery (minutes)

• Average time between last fetal heart rate (FHR) documented and delivery

8 months
Intrapartum fetal monitoring - Improved documentation (Risk factors for poor perinatal outcome)
Time Frame: 8 months

Average number of fetal risk factors documented per mother

• Risk factors for poor perinatal outcome

8 months
Intrapartum fetal monitoring - Cardiotocography (CTG) meetings
Time Frame: 8 months

Average number of cases discussed per meeting

• Number of cases (CTGs and poor perinatal outcomes) discussed

8 months
Training - number of staff trained
Time Frame: 8 months
Number of staff trained as a percentage of the number of eligible staff. Senior doctors Residents Nurses/midwives Students
8 months
Training - Improvement in pre and post test scores
Time Frame: 8 months
Percentage change between pre and post test scores, per staff member trained
8 months
Training - Improvement in self perceived knowledge and confidence about intrapartum fetal monitoring
Time Frame: 8 months
Mean Likert score
8 months
Training - satisfaction and feedback about training
Time Frame: 8 months
Survey data from staff attending training. Semi-structured questions.
8 months
Maternal - Caesarean section rate overall
Time Frame: 8 months
Number of cases of caesarean section/month as a % of all births
8 months
Maternal - Operative vaginal delivery rate
Time Frame: 8 months
Number of cases of operative delivery/month as a % of all births
8 months
Maternal - Maternal length of hospital stay
Time Frame: 8 months
Average length of maternal stay/per patient/month
8 months
Maternal - Maternal death
Time Frame: 8 months
Total number of maternal deaths/month
8 months
Perinatal - Apgar score
Time Frame: 8 months
Number of cases of Apgar score 7 or below at 5 minutes/month as a percentage of all births
8 months
Perinatal - Cord blood lactate
Time Frame: 8 months
Number of cases of cord blood lactate 4.9 mmol/l or above/month as a percentage of all births
8 months
Perinatal - Neonatal resuscitation
Time Frame: 8 months
Number of babies requiring resuscitation/month as a percentage of all births
8 months
Perinatal - Neonatal intensive care unit (NICU) admission
Time Frame: 8 months
Number of NICU admissions/month as a percentage of all births
8 months
Perinatal - Length of NICU stay
Time Frame: 8 months
Average number of days/admission/month
8 months
Perinatal - Neonatal morbidity
Time Frame: 8 months
Number of cases of birth asphyxia/HIE per month as a percentage of all births
8 months
Perinatal - Perinatal death before discharge
Time Frame: 8 months
Number of perinatal deaths/month as a percentage of all births
8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2019

Primary Completion (ACTUAL)

March 16, 2020

Study Completion (ACTUAL)

March 16, 2020

Study Registration Dates

First Submitted

July 26, 2019

First Submitted That Met QC Criteria

September 9, 2019

First Posted (ACTUAL)

September 10, 2019

Study Record Updates

Last Update Posted (ACTUAL)

November 20, 2020

Last Update Submitted That Met QC Criteria

November 19, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intrapartum Fetal Monitoring

Clinical Trials on Intrapartum fetal monitoring training and quality improvement project

Subscribe